Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$3.34 USD
-0.02 (-0.60%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.35 +0.01 (0.30%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Clover Health Investments, Corp. (CLOV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$1.67 | $2.00 | $1.00 | -50.30% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Clover Health Investments, Corp. comes to $1.67. The forecasts range from a low of $1.00 to a high of $2.00. The average price target represents a decline of 50.3% from the last closing price of $3.36.
Analyst Price Targets (3 )
Broker Rating
Clover Health Investments, Corp. currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CLOV.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/3/2024 | Not Identified | Not Identified | Hold | Hold |
3/1/2024 | SVB Securities | Whit Mayo | Hold | Hold |
1/29/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 3 |
Average Target Price | $1.67 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | -0.03 |